IVIG Safe and Effective to Treat Moderate Pneumonia in COVID-19 Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Infectious Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in COVID-19 Patients With Regular Intravenous Immunoglobulin Therapy
J. Infect. Dis 2021 Feb 15;[EPub Ahead of Print], RS Raman, VB Barge, AK Darivenula, H Dandu, RR Kartha, V Bafna, VT Aravinda, TC RaghuramFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.